BRCA2 and cancer: GT/C has been used as a standard model in high-income countries,14 and is suggested to increase cancer-related knowledge, perceived personal control, and risk perception accuracy, and decrease cancer-related anxiety and decisional conflict among patients.15 Further, GT can affect surgical planning and play an essential role in the treatment course.16-18 In TNBC, deleterious mutations have been reported at higher rates, and GT/C for BRCA1 and BRCA2 has been recommended regardless of age or family history.19